Vimarsana
Biggest News Aggregation in the World

Page 40 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Lonza sells processing plant in Quakertown, Pa. - Chemical Engineering - Vimarsana News

Lonza sells processing plant in Quakertown, Pa. - Chemical Engineering

(Page 1) Lonza AG (Basel, Switzerland) announced an agreement for the sale of its Quakertown, Pa. site to a group of industry veterans and investors. The agreement

Lonza Sells Particle Size Reduction Facility - Vimarsana News

Lonza Sells Particle Size Reduction Facility

The firm announced it entered into a deal to divest the Quakertown, PA location to a group of investors.

Lonza Group AG (OTCMKTS:LZAGY) Sees Large Drop in Short Interest - Vimarsana News

Lonza Group AG (OTCMKTS:LZAGY) Sees Large Drop in Short Interest

Lonza Group AG (OTCMKTS:LZAGY – Get Rating) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 2,400 shares, a decrease of 35.1% from the March 31st total of 3,700 shares. Based on an average daily trading volume, of 111,600 shares, the days-to-cover ratio […]

Advancing a Treatment for a Common Eye Disease That Lacks One - Vimarsana News

Advancing a Treatment for a Common Eye Disease That Lacks One

The road from discovering a potential drug to getting the therapy into the hands of patients is a long and uncertain one. An NIH program offers researchers a sm

Lonza Group AG (OTCMKTS:LZAGY) Receives $900.00 Average Target Price from Analysts - Vimarsana News

Lonza Group AG (OTCMKTS:LZAGY) Receives $900.00 Average Target Price from Analysts

Shares of Lonza Group AG (OTCMKTS:LZAGY – Get Rating) have received a consensus recommendation of “Buy” from the ten analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and six have assigned a buy recommendation to the company. The […]